Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000898430-07-003031
Filing Date
2007-08-16
Accepted
2007-08-16 19:36:13
Documents
1
Period of Report
2007-08-14

Document Format Files

Seq Description Document Type Size
1 AUGUST PURCHASE #2 rrd169852.html 4  
1 AUGUST PURCHASE #2 rrd169852.xml 4 9546
  Complete submission text file 0000898430-07-003031.txt   11564
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Issuer) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 161 WEST 61ST STREET NEW YORK NY 10022
Business Address 161 WEST 61 STREET NEW YORK NY 10023 2125818170
GOLDFISCHER CARL (Reporting) CIK: 0001110780 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16614 | Film No.: 071063650